|
|
|
| Welcoming over 9,000+ industry professionals, INTERPHEX is the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. It's where the newest ideas are shared, technology is unveiled, and the power of science though commercialization comes to life. No matter where you are in the pharmaceutical development lifecycle, INTERPHEX delivers relevant solutions to drive growth and fuel scalability for your business. Learn more |
|
|
|
|
By Drug Delivery Leader: Sit And Deliver | Drug overdoses can result both from knowingly risky behavior, such as opioid use disorder, and from unwitting patient acts of over-consumption. In this episode of Sit and Deliver, Greg Sturmer, co-founder and CEO of biopharmaceutical company Elysium Therapeutics, talks about ways to add overdose inhibitors to oral medications prone to abuse or misuse. |
|
|
Battelle's Gabe Meister And Tony Duong Talk Gene Therapy Delivery | By Drug Delivery Leader: Supplier Horizons | A significant challenge in gene therapy delivery – particularly for in vivo approaches – has been limitations in cargo capacity of the gene payload carrier. In this episode of Supplier Horizons, host Tom von Gunden talks with technical director Gabe Meister and scientist Tony Duong from biopharmaceutical research and development company Battelle about the promise of polymer nanoparticles as delivery vehicles for treating rare diseases with in vivo gene therapies. |
|
|
|
|
|
|
|
| Developmental Testing Of IV Solutions | Article | By Ryan Memmer, Singota Solutions | As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration. |
|
|
|
|
|
|
|
.png){kind=logo}
